Correction: Rockman et al. Cell-Based Manufacturing Technology Increases Antigenic Match of Influenza Vaccine and Results in Improved Effectiveness.
Vaccines
2023,
11
, 52
Vaccines (Basel)
.
2023 Dec 11;11(12):1839.
doi: 10.3390/vaccines11121839.
Authors
Steven Rockman
1
2
,
Karen Laurie
1
,
Chi Ong
1
,
Sankarasubramanian Rajaram
3
,
Ian McGovern
4
,
Vy Tran
5
,
John Youhanna
4
Affiliations
1
CSL Seqirus Ltd., Parkville, VIC 3050, Australia.
2
Department of Immunology and Microbiology, The University of Melbourne, Parkville, VIC 3050, Australia.
3
CSL Seqirus Ltd., Maidenhead SL6, UK.
4
CSL Seqirus Ltd., Summit, NJ 07901, USA.
5
CSL Seqirus Ltd., Kirkland, QC H9H 4M7, Canada.
PMID:
38140271
PMCID:
PMC10747401
DOI:
10.3390/vaccines11121839
Abstract
The authors would like to make the following corrections to this published paper [...].
Publication types
Published Erratum